SCHEMBL29573470

SCHEMBL29573470

CCNc1nc(Cl)nc2c1ncn2[C@H]1[C@H](O)[C@H](O)[C@]2(C(F)F)C[C@H]12

nearest known ligand 0.62

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 13/20 0.62
▸ ADORA1 P30542 11/20 0.62
▸ HTR2B P41595 12/20 0.57
▸ HTR2C P28335 8/20 0.57
▸ ADORA2A P29274 4/20 0.57
▸ TMIGD3 P0DMS9 3/20 0.57
▸ SLC6A3 Q01959 2/20 0.54
▸ HTR1D P28221 3/20 0.54
▸ ADRA2B P18089 1/20 0.54
▸ ADRA2C P18825 2/20 0.53
▸ ADRB3 P13945 2/20 0.53
▸ HTR2A P28223 1/20 0.53
▸ OPRM1 P35372 1/20 0.53
▸ DRD4 P21917 1/20 0.53
▸ HSP90B1 P14625 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29573468 0.84 HTR2B (0.47) ADORA3ADORA1HTR2BHTR2CADORA2A
SCHEMBL29573969 0.83 HRH2 (0.54) ADORA3ADORA1HTR2BHTR2CADORA2A
SCHEMBL29574436 0.79 ADORA1 (0.57) ADORA3ADORA1HTR2BHTR2CADORA2A
SCHEMBL12805062 0.77 ADORA3 (1.00) ADORA3ADORA1HTR2BHTR2CADORA2A
SCHEMBL29573781 0.76 HTR2B (0.73) ADORA3ADORA1HTR2BHTR2CADORA2A
SCHEMBL29574509 0.75 ADORA3 (0.52) ADORA3ADORA1HTR2BHTR2CTMIGD3
SCHEMBL6818080 0.73 ADORA3 (0.61) ADORA3ADORA1ADORA2A
SCHEMBL19464941 0.72 HTR2B (1.00) ADORA3ADORA1HTR2BHTR2CADORA2A
SCHEMBL19464934 0.72 HTR2B (1.00) ADORA3ADORA1HTR2BHTR2CADORA2A
SCHEMBL19464867 0.72 HTR2B (1.00) ADORA3ADORA1HTR2BHTR2CADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116457356-A A3 adenosine receptor agonists for use in medicine 生物干预公司 2023-07-18 — — CN disclosed
EP-4196219-A1 A3 ADENOSINE RECEPTOR AGONISTS FOR USE IN MEDICINE Biointervene, Inc. (US) 2023-06-21 — — EP disclosed
WO-2022040241-A1 A3 ADENOSINE RECEPTOR AGONISTS FOR USE IN MEDICINE BIOINTERVENE, INC. (US) 2022-02-24 — — WO disclosed
Send feedback